Skip to main content

Chloroquine News

FDA Medwatch Alert: Remdesivir by Gilead Sciences: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of Treatment

ISSUE: FDA is warning health care providers that co-administration of remdesivir and chloroquine phosphate or hydroxychloroquine sulfate is not recommended as it may result in reduced antiviral...

FDA Medwatch Alert: Drug Safety Communication: Hydroxychloroquine or Chloroquine for COVID-19 - FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems

ISSUE: FDA is concerned that hydroxychloroquine and chloroquine are being used inappropriately to treat non-hospitalized patients for coronavirus disease (COVID-19) or to prevent that disease.  We ...

Chloroquine and Hydroxychloroquine Under Investigation for COVID-19

US to conduct clinical trials of chloroquine for COVID-19 Clinical trials of chloroquine and its less toxic metabolite, hydroxychloroquine, are ongoing or due to start in other countries. Both drugs...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Chloroquine patient information at Drugs.com